InvestorsHub Logo
Followers 54
Posts 5472
Boards Moderated 0
Alias Born 10/28/2008

Re: markgovols post# 34154

Monday, 08/01/2011 12:43:23 PM

Monday, August 01, 2011 12:43:23 PM

Post# of 77519
Their biotech assets are worth ALOT of $$$$$$. Not factored into the stock at all. A few Celgene like deals made here and there will make this company worth $100's of millions of dollars on strictly the biotech only. Factor in the medical records side and how they have the best PHR on the market along with MMR Pro which is a great solution to expensive scanning and EMR conversions and you can see why I do what I do.....

UPDATE: Celgene's 2Q Earnings Rose 80%; 2011 View Boosted
--Revlimid sales drive growth, increase in 2011 projections
http://online.wsj.com/article/BT-CO-20110728-718898.html

Celgene currently has six marketed treatments. Two of these treatments can be attributed to Revlimid.

http://seekingalpha.com/article/281403-identifying-biopharma-companies-that-push-the-sector-higher
===========================================================================================================
MMRF/Celgene/Revlimid
http://www.docstoc.com/docs/75832765/Non-exclusive-License-Agreement---MMR-INFORMATION-SYSTEMS----3-31-2011

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.